Kalohexis Files Confidentially for U.S. IPO
Kalohexis, a clinical-stage biotech based in Northbrook, IL, has confidentially filed with the SEC for an initial public offering (IPO) to raise capital as it develops peptide therapies targeting obesity and related conditions.
